Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

[31] Cooper W(2020)Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response J Immunother Cancer 77 3540-61

[32] Dacic S(2017)Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma Cancer Res 27 202-396

[33] Hirsch FR(2021)Genome and transcriptome biomarkers of response to immune checkpoint inhibitors in advanced solid tumors Clin Cancer Res 511 543-2116

[34] Jain D(2014)Comprehensive molecular profiling of lung adenocarcinoma Nature 489 519-408

[35] Aguiar PN(2012)Comprehensive genomic characterization of squamous cell lung cancers Nature 16 4864-391

[36] De Mello RA(2010)Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types Clin Cancer Res 39 782-530

[37] Hall P(2013)Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer Immunity 107 6994-237

[38] Tadokoro H(2010)A pathway-based classification of human breast cancer Proc Natl Acad Sci USA 160 48-641

[39] de Lima Lopes G(2015)Molecular and genetic properties of tumors associated with local immune cytolytic activity Cell 8 e000974-1286

[40] Kerr KM(2020)Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma J Immunother Cancer 30 385-13781

[31] Cooper W(2020)Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response J Immunother Cancer 77 3540-61

[32] Dacic S(2017)Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma Cancer Res 27 202-396

[33] Hirsch FR(2021)Genome and transcriptome biomarkers of response to immune checkpoint inhibitors in advanced solid tumors Clin Cancer Res 511 543-2116

[34] Jain D(2014)Comprehensive molecular profiling of lung adenocarcinoma Nature 489 519-408

[35] Aguiar PN(2012)Comprehensive genomic characterization of squamous cell lung cancers Nature 16 4864-391

[36] De Mello RA(2010)Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types Clin Cancer Res 39 782-530

[37] Hall P(2013)Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer Immunity 107 6994-237

[38] Tadokoro H(2010)A pathway-based classification of human breast cancer Proc Natl Acad Sci USA 160 48-641

[39] de Lima Lopes G(2015)Molecular and genetic properties of tumors associated with local immune cytolytic activity Cell 8 e000974-1286

[40] Kerr KM(2020)Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma J Immunother Cancer 30 385-13781